Human trophoblast function during the implantation process

Reproductive Biology and Endocrinology

Volumn 3, Issue , 2005, Pages

  Staun Ram, Elsebeth ^a,b   Shalev, Eliezer ^a,b  

^a HAEMEK MEDICAL CENTER   (Israel)

^b TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

CELL ADHESION MOLECULE; CHORIONIC GONADOTROPIN; EPIDERMAL GROWTH FACTOR; HEPARIN BINDING EPIDERMAL GROWTH FACTOR; INTEGRIN; INTERLEUKIN 1; LEUKEMIA INHIBITORY FACTOR; MATRIX METALLOPROTEINASE; MUCIN 1; PROGESTERONE; PROSTAGLANDIN; SCLEROPROTEIN; SERINE PROTEINASE; SOMATOMEDIN BINDING PROTEIN 1; TISSUE INHIBITOR OF METALLOPROTEINASE; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; CORTICOTROPIN RELEASING FACTOR; HEPARIN-BINDING EGF-LIKE GROWTH FACTOR; IGFBP1 PROTEIN, HUMAN; INTERLEUKIN 6; LIF PROTEIN, HUMAN; SIGNAL PEPTIDE; VASCULOTROPIN A; VEGFA PROTEIN, HUMAN;

BLASTOCYST; CELL FUNCTION; CELL INTERACTION; CELL MIGRATION; CELL PROLIFERATION; CELLULAR DISTRIBUTION; EMBRYO; EMBRYO DEVELOPMENT; ENDOMETRIUM; GENE EXPRESSION; HUMAN; MOLECULAR MECHANICS; NIDATION; NONHUMAN; PARACRINE SIGNALING; PROTEIN FUNCTION; PROTEIN LOCALIZATION; REVIEW; TROPHOBLAST; ANIMAL; FEMALE; PHYSIOLOGY;

ANIMALS; CELL ADHESION MOLECULES; CHORIONIC GONADOTROPIN; CORTICOTROPIN-RELEASING HORMONE; EMBRYO IMPLANTATION; EPIDERMAL GROWTH FACTOR; EXTRACELLULAR MATRIX PROTEINS; FEMALE; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 1; INTEGRINS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; INTERLEUKIN-1; INTERLEUKIN-6; LEUKEMIA INHIBITORY FACTOR; MATRIX METALLOPROTEINASES; MUCIN-1; PROGESTERONE; PROSTAGLANDINS; SERINE ENDOPEPTIDASES; TISSUE INHIBITOR OF METALLOPROTEINASES; TRANSFORMING GROWTH FACTOR BETA; TROPHOBLASTS; TUMOR NECROSIS FACTOR-ALPHA; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 27744472865     PISSN: 14777827     EISSN: 14777827     Source Type: Journal    
DOI: 10.1186/1477-7827-3-56     Document Type: Review

References (150)

1. Krüssel. JS, Bielfeld P, Polan ML, Simón C: Regulation of embryonic Implantation. European Journal of Obstetrics and Gynecology and Reproductive Biology 2003, 110:2-9
2. Bischof P, Campana A: Molecular mediators of implantation. Bailliere's Clinical Obstetrics and Gynaecology 2000, 14 (5): 801-814.
3. Vigano P, Mangioni S, Pompei F, Chiodo I: Maternal-conceptus Cross Talk - A Review. Placenta 2003, 24:S56-S61.
4. Norwitz ER, Schust DJ, Fisher SJ: Implantation and the survival of early pregnancy. N Engl J Med 2001, 345:1400-1408.
5. Lopata A, Bentin-Ley U, Enders A: "Pinopodes" and Implantation. Reviews in Endocrine & metabolic Disorders 2002, 3:77-86.
6. Carver JC, Martin K, Spyropoulou I, Barlow D, Sargent I, Mardon H: An in-vitro model for stromal invasion during implantation of the human blastocyst. Human Reproduction 2003, 18(2): 283-290]
7. Nacas G: Pinopodes as markers of endometrial receptivity in clinical practice. Hum Reprod 1999,14 Suppl 2:99-106.
8. Burghardt RC, Johnson GA, Jarger LA, Ka H, Garlow JE, Spencer TE, Bazer FW: Integrins and Extracellular Matrix Proteins at the Maternal-Fetal Interface in Domestic Animals. Cell Tissues Organs 2002, 172:202-217.
9. Lessey BA: Endometrial integrins. Endocrinologist 1995, 5:214-221.
10. Lessey BA, Castelbaum AJ, Buck CA, Lei Y, Yowell CW, Sun J: Further characterization of endometrial integrins during the menstrual cycle and in pregnancy. Fertil Steril 1994,62(3): 497-506.
11. Lessey BA: Endometrial integrins and the establishment of uterine receptivity. Hum Reprod 1998, 13 Suppl 3:247-258; discussion 259-261.
12. Nardo LG, Nikas G, Makrigiannakis A, Sinatra F, Nardo F: Synchronous expression of pinopodes and alpha v beta 3 and alpha 4 beta 1 integrins in the endometrial surface epithelium of normally menstruating women during the implantation window. J Reprod Med 2003, 48(5): 355-361.
13. Lessey BA, Castelbaum AJ, Sawin SW, Sun J: Integrin as markers of uterine receptivity in women with primary unexplained infertility. Fertil Steril 1995, 63(3): 535-542.
14. Lessey BA, Ilesanmi AO, Lessey MA, Riben M, Harris JF, Chwalisz K: Luminal and glandular endometrial epithelium express integrins differentially throughout the menstrual cycle: implications for implantation, contraception and infertility. Am J Reprod Immunol 1996, 35: 195-204.
15. Skrzypczak J, Mikolajczyk M, Szymanowski K: Endomatrial receptivity: expression of alpha3betal, alpha4betal and alpha Vbeta1 endometrial integrins in women with impaired fertility. Reprod Biol 2001, 1(2): 85-94.
16. Bowen JA and Hunt JS: The role of Integrins in Reproduction. Proc Soc Exp Biol Med 2000: 223(4): 331-43
17. Campbell S, Swann HR, Seif MW, Kimber SJ, Aplin JD: Cell adhesion molecules on the oocyte and preimplantation human embryo. Hum Reprod 1995, 10(6): 1571-1578.
18. Kabir-Salmani M, Shiokawa S, Akimoto Y, Sakai K, Nagamatsu S, Sakai S, Nakamura Y, Lofti A, Kawakami H, Iwashita M: Alphavbeta3 integrin signaling pathway is involved in insulin-like growth factor I-stimulated human extravillous trophoblast cell migration. Endocrinology 2003, 144(4): 1620-1630.
19. Kabir-Salmani M, Shiokawa S, Akimoto Y, Sakai K, Iwashita M: The role of alpha(5)beta(1)-integrin in the IGF-I-induced migration of extravillous trophoblast cells during the process of implantation. Mol Hum Reprod, 2004, 10(2): 91-97.
20. Stephens LE, Sutherland AE, Klimanskaya IV, Andrieux A, Meneses J, Pedersen RA, Damsky CH: Deletion of beta 1 integrin in mice results in inner cell mass failure and periimplantation lethality. Genes Dev 1995, 9(15): 1883-1895.
21. Simón C, Martin JC, Pellicer A: Paracerine regulators of implantation. Bailliere's Clinical Obstetrics and Gynaecology 2000, 14(5): 815-826.
22. Illera MJ, Cullinan E, Gui Y, Yuan L, Beyler SA, Lessey BA: Blockade of the α5β3 integrin adversely affects implantation in the mouse. Biol Reprod 2000, 62:1285-1290.
23. Aplin JD, Kimber SJ: Trophoblast-uterine interactions at implantation. Reproductive Biology and Endocrinology 2004, 2:48.
24. Dominguez F, Pellicer A, Simon C : Paracrine dialogue in implantation. Molecular and Cellular Endocrinology 2002, 186:175-181.
25. Meseguer M, Aplin JD, Caballero-Campo P, O'Connor JE, Martin JC, Remohi J, Pellicer A, Simon C: Human endometrial mucin MUC1 is up-regulated by progesterone and down-regulated in vitro by the human blastocyst. Biol Reprod 2001, 64:590-601.
26. Hill JA: Maternal-Embryonic Cross-Talk. Ann N Y Acad Sci 2001, 943:17-25.
27. Salamonsen LA, Shuster S, Stern R: Deposition of hyaluronan in human endometrium across the menstrual cycle: implications for implantation and menstruation. Cell Tissue Res 2001, 306:335-340.
28. Salamonsen LA, Nie G: Proteinases at the Endometrial-Trophoblast Interface: Their Role in Implantation. Reviews in Endocrine & Metabolic Disorders 2002, 3:133-143.
29. Xu P, Wang Y, Piao Y, Bai S, Xiao Z, Jia Y, Luo S, Zhuang L: Effects of Matrix Proteins on the Expression of Matrix Metalloproteinase-2, -9, and -14 and Tissue Inhibitors of Metalloproteinases in Human Cytotrophoblast Cells During the First Trimester. Biology of Reproduction 2001, 65:240-246.
30. Hofmann GE, Scott RT Jr, Bergh PA, Deligdisch L: Immunohistochemical localization of epidermal growth factor in human endometrium, decidua, and placenta. J Clin Endocrinol Metab 1991, 73(4): 882-887.
31. Bass KE, Morrish D, Roth I, Bhardwaj D, Taylor R, Zhou Y, Fisher SJ: Human Cytotrophoblast Invasion Is Up-regulated by Epidermal Growth Factor: Evidence That Paracrine Factors Modify This Process. Developmental Biology 1994, 164:550-561.
32. Staun-Ram E, Goldman S, Gabarin D, Shalev E: Expression and importance of matrix metalloproteinases 2 and 9 (MMP-2 and -9) in human trophoblast invasion. Reproductive Biology and Endocrinology 2004, 2(1): 59.
33. Maruo T, Matsuo H, Otani T, Mochizuki M: Role of epidermal growth factor (EGF) and its receptor in the development of the human placenta. Reprod Fertil Dev 1995, 7(6): 1465-1470.
34. Dakour J, Li H, Chen H, Morrish DW: EGF promotes development of a differentiated trophoblast phenotype having c-myc and junB proto-oncogene activation. Placenta. 1999, 20(1): 119-126.
35. Li RH, Zhuang LZ : The effect of growth factors on human normal placental cytotrophoblast cell proliferation. Hum Reprod 1997, 12(4): 830-834.
36. Anteby EY, Greenfield C, Natanson-Yaron S, Goldman-Wohl D, Hamani Y, Khudyak V, Ariel I, Yagel S: Vascular endothelial growth factor, epidermal growth factor and fibroblast growth factor-4 and -10 stimulate trophoblast plasminogen activator system and metalloproteinase-9. Mol Hum Reprod 2004, 10(4):229-235.
37. Qiu Q, Yang M, Tsang BK, Gruslin A: EGF-induced trophoblast secretion of MMP-9 and TIMP-1 involves activation of both P13K and MAPK signaling pathways. Reproduction 2004, 128(3): 355-363.
38. Nakatsuji Y, Nishio Y, Tani N, Adachi K, Ohmichi M, Hisamoto K, Morishige K, Kurachi H, Tasaka K, Murata Y, Matsuura N: Epidermal growth factor enhances invasive activity of BeWo choriocarcinoma cells by inducing alpha2 integrin expression. Endocr J 2003, 50(6): 703-714.
39. Graham CH, Connelly I, MacDougall JR, Kerbal RS, Stetler-Stevenson WG, Lala PK: Resistence of malignant trophoblast cells to both the anti-proliferative and anti-invasive effects of transforming growth factor beta. Experimental Cell Research 1994, 103:1641-1650.
40. Lash GE, Otun HA, Innes BA, Bulmer JN, Searle RF, Robson SC: Inhibition of Trophoblast Cell Invasion by TGFB1, 2, and 3 Is Associated with a Decrease in Active Proteases. Biol Reprod 2005, Apr 27 (in print).
41. Djurovic S, Schjetlein R, Wisloff F, Haugen G, Husby H, Berg K: Plasma concentrations of Lp(a) lipoprotein and TGF-bera1 are altered in preeclampsia. Clin Genet 1997, 52:371-376
42. Caniggia I, Winter J, Lye SJ, Post M: Oxygen and placental development during the first trimester: implications for the pathophysiology of pre-eclampsia. Placenta 2000,21 Suppl A: S25-30.
43. Bischof P, Meisser A, Campana A: Involvement of trophoblast in embryo implantation: regulation by paracrine factors. J Reprod Immunol 1998, 39(1-2): 167-177.
44. Hamilton GS, Lysiak JJ, Han VK, Lala PK: Autocrine-paracrine regulation of human trophoblast invasiveness by insulin-like growth factor (IGF)-II and IGF-binding protein (IGFBP)-1. Exp Cell Res 1998, 244(1): 147-156.
45. Irving JA, Lala PK: Functional role of cell surface integrins on human trophoblast cell migration: regulation by TGF-beta, IGF-II and IGFBP-1. Exp Cell Res 1995, 217(2): 419-427.
46. Stewart CL, Kaspar P, Brunet LJ, Bhatt H, Gadi I, Kontgen F, Abbondanzo SJ: Blastocyst implantation depends on maternal expression of leukaemia inhibitory factor. Nature 1992, 359(6390): 76-79.
47. Chen HF, Shew JY, Ho HN, Hsu WL, Yang YS: Expression of leukemia inhibitory factor and its receptor in preimplantation embryos. Fertil Steril 1999, 72(4): 709-713.
48. Sharkey AM, King A, Clark DE, Burrows TD, Jokhi PP, Charnock-Jones DS, Loke YW, Smith SK: Localization of leukemia inhibitory factor and its receptor in human placenta throughout pregnancy. Biology of reproduction 1999, 60:355-364.
49. Bischof P, Haenggeli L, Campana A: Effect of leukemia inhibitory factor on human cytotrophoblast differentiation along the invasive pathway. American Journal of Reproductive Immunology 1995, 34:225-230.
50. Bamberger AM, Jenatschke S, Schulte HM, Loning T, Bamberger MC: Leukemia inhibitory factor (LIF) stimulates the human HLA-G promoter in JEG3 chriocarcinoma cells. Endocrinol Metab 2000, 85(10): 3932-3936.
51. Vigano P, Mangioni S, Pompei F, Chiodo I: Maternal-conceptus Cross talk - A review. Placenta 2003, 24:56-61.
52. Simón C, Frances A, Piquette GN, el Danasouri I, Zurawski G, Dang W, Polan ML: Embryonic implantation in mice is blocked by interleukin-1 receptor antagonist. Endocrinology 1994, 134:521-528.
53. Meisser A, Chardonnens D, Campana A, Bischof P: Effects of tumour necrosis factor alpha, interleukin-I alpha, macrophage colony stimulating factor and transforming growth factor beta on trophoblastic matrix metalloproteinases. Molecular Human Reproduction 1999, 5:252-260.
54. Huang HY, Wen Y, Irvine JC, Kruessel JS, Soong YK, Polan ML: Cytokine mediated regulation of TIMP-1, TIMP-3 and 92-kDa Type IV collagenase messenger RNA expression in human endometrial stroma cells. J Clin Endiocrinology 1998, 83:1721-1729.
55. Meisser A, Cameo P, Islami D, Campana A, Bischof P: Effects of interleukin-6 (IL-6) on cytotrophoblastic cells. Molecular Human Reproduction 1999, 5: 1055-1058.
56. Roth I, Fisher SJ: IL-10 is an autocrine inhibitor of human placental cytotrophoblast MMP-9 production and invasion. Developmental Biology 1999, 205(1): 194-204.
57. Licht P, Russu V, Wildt L: On the role of human chorionic gonadotrophin (hCG) in the embryo-endometrial microenviroment: implications for differentiation and implantation. Semin Reprod Med 2001, 19:37-47.
58. Oktay K, Brzyski RG, Miller EB, Krugman D: Association of serum beta-hCG levels with myosalpingeal invasion and viable trophoblast mass in tubal pregnancy. Obstet Gynecol 1994, 84(5): 803-806.
59. Klein M, Graf A, Kiss H: The relation between depth of trophoblast invasion and beta-hCG levels in tubal pregnancies. Archives of Gynecology and Obstetrics 1995, 256:85-88.
60. Zygmunt M, Hahn D, Munstedt K, Bischof P, Lang U: Invasion of cytotrophoblastic JEG-3 cells is stimulated by hCG in vitro. Placenta 1998, 19:587-593.
61. Yagel S, Geva TE, Solomon H, Shimonovitz S, Reich R, Finci-Yeheskel Z, Mayer M, Milwidsky A: High levels of human chorionic gonadotropin retard first trimester trophoblast invasion in vitro by decreasing urokinase plasminogen activator and collagenase activities. J Clin Endocrinol Metab 1993, 77(6): 1506-1511.
62. Milwidsky A, Finci-Yeheskel Z, Yagel S, Mayer M: Gonadotropin-mediated inhibition of proteolytic enzymes produced by human trophoblast in culture. J Clin Endocrinol Metab 1993, 76(5): 1101-1105.
63. Zygmunt M, McKinnon T, Herr F, Lala PK, Han VK: HCG increases trophoblast migration in vitro via the insulin-like growth factor-II/ mannose-6 phosphate receptor. Mol Hum Reprod 2005, 11(4): 261-267.
64. Fazleabas AT, Donnelly KM, Srinivasan S, Fortman JD, Miller JB: Modulation of the baboon (Papio anubisx uterine endometrium by chorionic gonadotrophin during the period of uterine receptivity. Proc Natl Acad Sci USA 1999, 96(5): 2543-2548.
65. Srisuparp S, Strakova Z, Fazleabas AT: The role of chorionic gonadotrophin (CG) in blastocyst implantation. Arch Med Res 2001, 32(6): 627-634.
66. Cole LA, Khanlian SA, Sutton JM, Davies S, Stephens ND: Hyperglycosylated hCG (invasive trophoblast antigen, ITA) a key antigen for early pregnancy detection. Clin Biochem 2003, 36(8):647-655
67. Palomaki GE, Knight GJ, Roberson MM, Cunningham GC, Lee JE, Strom CM, Pandian R:Invasive trophoblast antigen (hyperglycosylated human chorionic gonadotropin) in second-trimester maternal urine as a marker for down syndrome: preliminary results of an observational study on fresh samples. Clin Chem 2004, 50(1):182-189.
68. Cole LA, Sutton JM, Higgins TN, Cembrowski GS:Between-method variation in human chorionic gonadotropin test results. Clin Chem 2004, 50(5): 874-882.
69. Bahado-Singh RO, Oz AU, Kingston JM, Shahabi S, Hsu CD, Cole L: The role of hyperglycosylated hCG in trophoblast invasion and the prediction of subsequent pre-eclampsia. Prenat Diagn 2002, 22(6):478-481
70. Dunn CL, Kelly RW, Critchley HO: Decidualization of the human endometrial stromal cell: an enigmatic transformation. Reprod Biomed Online 2003, 7(2): 151-161.
71. Spencer TE, Bazer FW: Conceptus signals for establishment and maintenance of pregnancy. Reproductive Biology and Endocrinology 2004, 2:49.
72. Shimonovitz S, Hurwitz A, Hochner-Celnikier D. Dushnik M, Anteby E, Yagel S: Expression of gelatinase B by trophoblast cells: down-regulation by progesterone. American Journal of Obstetrics and Gynecology 1998, 1788:457-461.
73. Goldman S, Shalev E: Difference in Progesterone Receptor Isoforms Ratio, Between Early and Late First Trimester Human Trophoblast, Is Associated with Differential Cell Invasion and Matrix Metalloproteinase2 (MMP2) Expression. Biol Reprod. 2005 Aug 31; [Epub ahead of print].
74. Dai B, Cao Y, Liu W, Yang Y, Chen D, Duan E: Dual roles of progesterone in embryo implantation in mouse Endocrine 2003, 21(2): 123-132.
75. Makrigiannakis A, Zoumakis E, Kalantaridou S, Coutifaris C, Margioris AN, Coukos G, Rice KC, Gravanis A, Chrousos GP: Cortoco-releasing hormone promotes blastocyst implantation and early maternal tolerance. Nature Immunology 2001,2(11): 1018-1023.
76. Athanassakis I, Farmakiotis V, Aifantis I, Gravanis A, Vassiliadis S: Expression of corticotrophin-releasing hormone in the mouse uterus: participation in embryo implantation. J Endocrinol 1999, 163(2): 221-227.
77. Bamberger AM, Shulte HM, Thuneke I, Erdmann I, Bamberger CM, Asa SL: Expression of the apoptosis-inducing Fas ligand (FasL) in human first and third trimester placenta and choriocarcinoma cells. J Clin Endocrinol Metab 1997, 82(9):3173-3175.
78. Karray S, Kress C, Cuvellier S, Hue-Beauvais C, Damotte D, Babinet C, Levi-Strauss M: Complete loss of Fas ligand gene causes massive lymphoproliferation and early death, indicating a residual activity of gld allele. J Immunol 2004, 172(4):2118-2125.
79. Muglia L, Jacobson L, Dikkes P, Majzoub JA: Corticotropin-releasing hormone deficiency reveals major fetal but not adult glucocorticoid need. Nature 1995, 373(6513):427-432.
80. Smith GW, Aubry JM, Dellu F, Contarino A, Bilezikjian LM, Gold LH, Chen R, Marchuk Y, Hauser C, Bently CA, Sawchenko PE, Koob GF, Vale W, Lee KF: Corticotropin releasing factor receptor 1-deficient mice display decreased anxiety, impaired stress response, and aberrant neuroendocrine development. Neuron 1998, 20(6): 1093-1102.
81. Hunt JS: Expression and regulation of the tumour necrosis factor-alpha gene in the female reproductive tract. Reprod Fertil Dev 1993, 5(2): 141-153.
82. Tabibzadeh S, Zupi E, Babaknia A, Liu A, Marconi D, Romanini C: Site and menstrual cycle-dependent expression of proteins of the tumour necrosis factor (TNF) receptor family, and BCL-2 oncoprotein and phase-specific production. Hum. Reprod 1995, 10, 277-286.
83. Yang Y, Yelavarthi KK, Chen HL, Pace JL, Tettanova PF, Hunt JS: Molecular biochemical and functional characteristics of tumor necrosis factor alpha produced by human placental cytotrophoblastic cells. J Immunol 1993, 150: 5614-5624.
84. Monzón-Bordonaba F, Vadillo-Ortega F, Feinberg RF: Modulation of trophoblast function by tumor necrosis factor-alpha: a role in pregnancy establishment and maintenance? Am J Obstet Gynecol 2002, 187(6): 1574-1580.
85. Hillier SL, Witkin SS, Khron MA, Watts DH, Kiviat NB, Eschenbach DA: The relationship of amniotic fluid cytokines and preterm delivery, amniotic fluid infection, histologic chorioamnionitis, and chorioamnion infection. Obstet Gyneco. 1993, 81(6): 941-948.
86. Bauer S, Pollheimer J, Hartmann J, Husslein P, Aplin JD, Knofler M: Tumor necrosis factor-alpha inhibits trophoblast migration through elevation of plasminogen activator inhibitor-1 in first-trimester villous explant cultures. Clin Endocrinol Metab 2004, 89(2): 812-822.
87. Benyo DF, Miles TM, Conrad KP: Hypoxia stimulates cytokine production by villous explants from the human placenta. J Clin Endocrinol Metab 1997, 82 (5): 1582-1588.
88. 2 enhances human endometrial stromal cell differentiation. Endocrinology 1994, 134:258-263.
89. Dimitriadis E, Stoikos C, Baca M, Fairlie WD, McCoubrie JE, Salamonsen LA: Relaxin and prostaglandin E(2) regulate interleukin 11 during human endometrial stromal cell decidualization. J Clin Endocrinol Metab 2005, 90(6): 3458-3465.
90. Shi JJ, Ma XH, Diao HL, Ni H, Xu LB, Zhu H, Yang ZM: Differential expression of prostaglandin E receptor subtype EP2 in rat uterus during early pregnancy. Histol Histopathol 2005, 20(4): 1021-1028.
91. Kao LC, Tulac S, Lobo S, Imani B, Yang JP, Germeyer A, Osteen K, Taylor RN, Lessey BA, Giudice LC:Global gene profiling in human endometrium during the window of implantation. Endocrinology 2002, 143(6): 2119-2138.
92. Dey SK: Fatty link to fertility. Nature 2005, 435:34-35.
93. Tan HN, Liu Y, Diao HL, Yang ZM: Cyclooxygenases and prostaglandin E synthases in preimplantation mouse embryos. Zygote 2005, 13(2): 103-108.
94. Westermarck J, Kahari VM: Regulation of matrix metalloproteinase expression in tumor invasion. FASEB J 1999, 13(8): 781-972.
95. Sternlicht MD, Werb Z: How Matrix Metalloproteinases Regulate Cell Behavior. Annu Rev Cell Dev Biol 2001, 17:463-516.
96. Hidalgo M, Eckhardt SG: Development of Matrix Metalloproteinase Inhibitors in Cancer Therapy. J Natl Cancer Inst 2001, 93(3): 178-193.
97. Fini ME, Cook JR, Mohan R, Brinckerhoff CE: Regulation of matrix metalloproteinase gene expression. In Matrix Metalloproteinases. Edited by Parks WC, Mecham RP. New York: Academic; 1998: 299-356.
98. Strongin AY, Collier I, Bannikov G, Marmer BL, Grant GA, Goldberg GI: Mechanism of cell surface activation of 72-kDa type IV collagenase. Isolation of the activated form of the membrane metalloproteinase. J Biol Chem 1995, 270:5331-5338.
99. Goldman S, Shalev E: The role of matrix metalloproteinases in human endometrial and ovarien cycles. European Journal of Obstetrics & Gynecology and Reproductive Biology 2003, 111:109-121.
100. Niu R, Okamoto T, Iwase K, Nomura S, Mizutani: Quantitative Analysis of Matrix Metalloproteinase-2 and -9 and their Tissue Inhibitors-1 and -2 in Human Placenta through gestation. Life Sciences 2000, 66(12): 1127-1137.
101. Dey SK, Lim H, Das SK, Reese J, Paria BC, Daikoku T, Wang H: Molecular Cues to Implantation. Endocrine Reviews 2004, 25(3): 341-373.
102. Librach C.L., Werb Z., Fitzgerald M.L., Chiu K., Corwin N.M., Esteves R.A., Grobelny D., Galardy R., Damsky C.H: 92-kDa type IV collagenase mediates invasion of human cytotrophoblasts. J Cell Biol 1991, 113, 437-449.
103. Bischof P, Matelli M, Campana A, Itoh Y, Ogata Y, Nagase H: Importance of metalloproteinases in human trophoblast invasion. Early Pregnancy Biology and Medicine 1995, 1(4): 263-269.
104. Xu P, Wang Y, Zhu S, Luo S, Piao Y, Zhuang L: Expression of Matrix Metalloproteinase-2, -9 and -14, Tissue Inhibitors of Metalloproteinse-1, and Matrix Proteins in Human Placenta During the First trimester. Biol Reprod. 2000, 62:988-994.
105. Isaka K, Usuda S, Ito H, Sagawa Y, Nakamura H, Nishi H, Suzuki Y, Li YF, Takayama M: Expression and Activity of Matrix Metalloproteinase 2 and 9 in Human Trophoblasts. Placenta 2003, 24:53-64.
106. Puistola U, Ronnberg L, Martikainen H, Turpeenniemi-Hujanen T: The human embryo produces basement membrane collagen (type IV collagen) degrading protease activity. Hum Reprod 1989, 4:309-311.
107. Turpeenniemi-Hujanen T, Feinberg RF, Kauppila A, Puistola U: Laminin in the human embryo implantation: analog to the invasion by malignant cells. Fertil Steril 1992,58:105-113.
108. Wang Y, Zhang Y, Lewis DF, Gu Y, Li H, Granger DN, Alexander JS: Protease chymotrypsin mediates the endothelial expression of P-and E-selectin, but not ICAM and VCAM, induced by placental trophoblasts from pre-eclamptic pregnancies. Placenta 2003, 24(8-9): 851-861.
109. Yu Q, Stamenkovic I: Cell surface-localized matrix metalloproteinases-9 proteolytically activates THF-beta and promotes tumor invasion and angiogenesis. Genes Dev 2000, 14:163-176.
110. Martin DC, Fowlkes JL, Babic B, KhokhaR: Insulin-like growth factor II signaling in neoplastic proliferation is blocked by transgenic expression of the metalloproteinase inhibitor TIMP- 1. J Cell Biol 1999, 146:881-892.
111. Fernandez-Patron C, Radomski MW, Davidge ST: Vascular matrix metalloproteinase-2 cleaves big endothelin-1 yielding a noval vasoconstrictor. Circ Res 1999, 85:906-911.
112. Patterson BC, sang QA : Angiostatin-converting enzyme activities of human matrilysin (MMP-7) and gelatinase B/type IV collagenase (MMP-9). J Biol Chem 1997, 272:28823-28825.
113. Itoh T, Ikeda T, Gomi H, Nakao S, Suzuki T, Itohara S: Unaltered secretion of beta-amaloid precursor protein in gelatinase A (matrix metalloproteinase 2)-deficient mice. J Biol Chem 1997, 272(36): 22389-22392.
114. Dubois B, Arnold B, Opdenakker G: Gelatinase B deficiency impairs reproduction. J Clin Invest 2000, 106(5): 627-628.
115. Holmbeck K, Bianco P, Caterina J, Yamada S, Kromer M, Kuznetsov SA, Mankani M, Robey PG, Poole AR, Pidoux I, Ward JM, Birkedal-Hansen H: MT1-MMP-deficient mice develop dwarfism, osteopenia, arthritis, and connective tissue disease due to inadequate collagen tuerover. Cell 1999, 99(1): 81-92.
116. Rudolph-Owen LA, Hulboy DL, Wilson CL, Mudgett J, Matrisian LM: Coordinate expression of matrix metalloproteinase family members in the uterus of normal, matrilysin-deficient, and stromelysin 1-deficient mice. Endocrinol 1997, 138:4902-4911.
117. Pendas AM, Balbin M, Llana E, Jimenez MG, Lopez-Otin C: Structural analysis and promoter characterization of the human collagenase-3 gene (MMP13). Genomics 1997, 40:222-33.
118. Bischof P, Truong K, Campana A: Regulation of Trophoblastic Gelatinases by Proto-oncogenes. Placenta 2003, 24:155-163.
119. Yamamoto H, Flannery ML, Kupriyanov S, Pearce J, McKercher SR, Henkel GW, Maki RA, Werb Z, Oshima RG: Defective trophoblast function in mice with a targeted mutation of Ets2. Genes Dev 1998, 12(9): 1315-1326.
120. Wang HZ, Zhao YG, Wang HM, Yang Q, Lin HY, Sang QX, Zhu C: Expression of adamalysin 19/ADAM19 in the endometrium and placenta of rhesus monkey (Macaca mulatta) during early pregnancy, Mol Hum Reprod 2005, 11(6): 429-435.
121. Baker AH, Edwards DR, Murphy G: Metalloproteinase inhibitors: biological actions and therapeutic opportunities. J Cell Sci 2002, 115(Pt 19): 3719-3727.
122. Goldberg GI, Strongin A, Collier IE, Genrich LT, Marmer BL: Interaction of 92 kDa type IV collagenase with the tissue inhibitor of metalloproteinases prevents dimerization, complex formation with interstitial collagenase, and activation of the pro-enzyme with stromelysin. J Biol Chem 1992, 267:4583-4591.
123. Stetler-Stevenson WG, Krutzsch HC, Liotta LA: Tissue inhibitor of metalloproteinase-2 (TIMP-2), a new member of metalloproteinase inhibitor family. J Biol Chem 1989, 264:17374-17378.
124. Hurskainen T, Hoyhtya M, Tuuttila A, Oikarinen A, Autio-Harmainen H: mRNA expression of TIMP-1, -2 and -3 and 92-kDa type IV collagenase in early human placenta and decidual membrane as studied by in situ hybridization. J Histochem Cytochem 1996, 44:1379-1388.
125. Ruck P, Marzusch K, Horny H-P, Diet J, Kaiserling E. The distribution of tissue inhibitor of metalloproteinases-2 (TIMP-2) in the human placenta. Placenta 1996; 17:263-266.
126. Zhang J, Zhao YG, Cao YJ, Sang QX, Duan EK: Expression and implications of tissue inhibitor of metalloproteinase-4 in mouse embryo. Mol Hum Reprod 2003, 9(3): 143-149.
127. Zhang J, Cao YJ, Zhao YG, Sang QX, Duan EK: Expression of matrix metalloproteinase-26 and tissue inhibitor of metalloproteinase-4 in human normal cytotrophoblast cells and a choriocarcinoma cell line, JEG-3. Mol Hum Reprod 2002, 8(7): 659-666.
128. Wang H, Wen Y, Mooney S, Li H, Behr B, Polan ML: Matrix metalloproteinase and tissue inhibitor of matrix metalloproteinase expression in human preimplantation embryos. Fertility and Sterility 2003, 80(suppl 2): 736-742.
129. Chakraborty C, Gleeson LM, McKinnon T, Lala PK: Regulation of human trophoblast migration and invasiveness. Can J Physiol Pharmacol 2002, 80(2): 116-124.
130. Hayakawa T Yamashita K, Uchijima M, Iwata K: Growth-promoting activity of tissue inhibitor of metalloproteinases (TIMP-1) for a wide range of cells. FEBS Letters 1992, 298:29-32.
131. Hayakawa T Yamashita K, Ohuchi E, Shinagawa A: Cell Growth promoting activity of tissue inhibitor of metalloproteinase-2 (TIMP-1). J Cell Sci 1994, 107:2372-2379.
132. Satoh T, Kobayashi K, Yamashita S, Kikuchi M, Sendai Y, Hoshi H: Tissue inhibitor of metalloproteinases (TIMP-1) produced by granolosa and oviduct cells enhances in vitro development of bovine embryos. Biol Reprod 1994, 50:835-844.
133. Vassalli JD, Sappino AP, Berlin D: The plasminogen activator/plasmin system. J Clin Invest 1991, 88:1067-1072.
134. Nordengren J, Pilka R, Noskova V, Ehinger A, Domanski H, Andersson C, Hoyer-Hansen G, Hansson SR, Casslen B: Differential localization and expression of urokinase plasminogen activator (uPA), its receptor (uPAR), and its inhibitor (PAI-1) mRNA and protein in endometrial tissue during the menstrual cycle. Mol Hum Reprod 2004, 10(9): 655-663.
135. Floridon C, Nielsen O, Holund B, Sunde L, Westergaard JG, Thomsen SG, Teisner B: Localization and significance of urokinase plasminogen activator and its receptor in placental tissue from intrauterine, ectopic and molar pregnancies. Placenta 1999, 20(8): 711-721
136. Aflalo ED, Sod-Moriah UA, Potashnik G, Har-Vardi I: Differences in the implantation rates of rat embryos developed in vivo and in vitro: possible role for plasminogen activators. Fertil Steril 2004, 81 Suppl 1:780-785.
137. Zhang X, Green KE, Yallampalli C, Dong YL: Adrenomedullin Enhances Invasion by Trophoblast Cell Lines. Biol Reprod 2005, [Epub ahead of print.
138. Moriyama T, Otani T, Matyo T: Expression of adrenomedullin by human placental cytotrophoblasts and choriocarcinoma JAr cells. J Clin Endocrinol Metab. 2001, 86(8): 3958-3961.
139. Carmeliet P, Ferreira V, Breier G, Pollefeyt S, Kieckens L, Gertsenstein M, Fahrig M, Vandenhoeck A, Harpal K, Eberhardt C, Declercq C, Pawling J, Moons L, Collen D, Risau W, Nagy A: Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature 1996, 380(6573): 435-439.
140. Shore VH, Wang CL, Torry RJ, Caudle MR, Torry DS: Vascular endothelial growth factor, placenta growth factor and their receptors in isolated human trophoblast. Placenta 1997, 18:657-665.
141. Cooper JC, Sharkey AM, Charnock-Jones DS, Palmer CR, Smith SK: VEGF mRNA levels in placentae from pregnancies complicated by pre-eclampsia. Br J Obstet Gynaecol 1996, 103(12): 1191-1196.
142. Torry DS, Wang HS, Wang TH, Caudle MR, Torry RJ: Preeclampsia is associated with reduced serum levels of placenta growth factor. Am J Obstet Gynecol 1998, 179(6 Pt 1): 1539-1544.
143. Chung IB, Yelian FD, Zaher FM, Gonik B, Evans MI, Diamond MP, Svinarich DM: Expression and Regulation of Vascular Endothelial Growth Factor in a First Trimester Trophoblast Cell Line. Placenta 2000, 21:320-324.
144. Llurba E, Gratacos E, Martin-Gallan P, Cabero L, Dominquez C: A comprehensive study of oxidative stress and antioxidant status in preeclampsia and normal pregnancy. Free Radic Biol Med 2004, 37(4): 557-570.
145. Hung TH, Charnock-Jones DS, Skepper JN, Burton GJ: Secretion of tumor necrosis factor-alpha from human placental tissues induced by hypoxia-reoxygenation causes endothelial cell activation in vitro: a potential mediator of the inflammatory response in preeclampsia. Am J Pathol 2004, 164(3): 1049-1061.
146. Vadachkoria S, Sanchez SE, Qiu C, Muy-Rivera M, Malinow MR, Williams MA: Hyperhomocyst(e)inemia and elevated soluble vascular cell adhesion molecule-1 concentrations are associated with an increased risk of preeclampsia. Gynecol Obstet Invest 2004, 58(3): 133139.
147. Tziotis J, Malamitsi-Puchner A, Vlaschos G, Creatsas G, Michalas S: Adhesion molecules expression in the placental bed of pregnancies with pre-eclampsia. BJOG 2002, 109(2): 197-201.
148. Liu Q, Yan X, Li Y, Zhang Y, Zhao X, Shen Y: Pre-eclampsia is associated with the failure of melanoma cell adhesion molecule (MCANVCD146) expression by intermediate trophoblast. Lab Invest 2004, 84(2): 221-228.
149. Rajashekhar G, Loganath A, Roy AC, Wong YC: Expression and secretion of the vascular cell adhesion molecule-1 in human placenta and its decrease in fetal growth restriction. J Soc Gynecol Investig 2003, 10(6): 352-360.
150. Matsubara K, Abe E, Ochi H, Kusanagi Y, Ito M: Changes in serum concentrations of tumor necrosis factor alpha and adhesive molecules in normal pregnant women and those with pregnancy-induced hypertension. J Obstet Gynaecol Res 2003, 29(6): 422-426.